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BACKGROUND: Thyroid dysfunction accounts for majority of 
endocrine disorders. In sub-Saharan Africa Graves’ disease and 
hypothyroidism have accounted for 13.1% and 8.8% while the 
burden of thyroid disorder has ranged from 6.18 to47.34% among 
countries in the Arab world. The cost for a primary thyroid test 
done to evaluate the gland function constituted a large proportion 
of the public health budget. For instance, 10 million thyroid 
functions have been done each year by laboratories which cost 30 
million UK pounds, and they represent 8% of laboratory charge in 
the US. When a TSH-only protocol (guideline) was used, 95% of 
the requests were sufficient for diagnosis without requiring further 
tests, thereby resulting in 50% savings on FT4 reagent and 
reducing the annual TFT reagent cost by 25%. This is an original 
study, and its objective was to assess the ordering pattern of TSH 
tests and their cost-effectiveness in patients’ samples referred to 
ICL from   Addis Ababa health facilities between July2015 to June 
2016 
METHOD: An institution-based cross-sectional study design was 
utilized to study the ordering pattern of thyroid function tests using 
one-year retrospective data from ICL.  
RESULTS:  Thyroid profiles were ordered more frequently 
(49.5%) compared to TSH only (24.3%). An additional 2625.70 
USD was paid by patients for individual components in the profile 
tests that turned out normal. 
CONCLUSION:  Guidelines advocate TSH as the initial test for 
thyroid dysfunction, but the use of a combination of tests is more 
common. 
KEYWORDS: Thyroid stimulating hormone, Thyroid 




Thyroid dysfunction accounts for the majority of endocrine disorders 
(1). In sub-Saharan Africa, Graves’ disease and hypothyroidism have 
accounted for 13.1% and 8.8% while the burden of thyroid disorder 
has ranged from 6.18 to 47.34% among countries in the Arab world           
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(2,3). Endemic goiter  has been found in 28.6% in 
the community of Sekota, Ethiopia (3). The cost for 
a primary thyroid test done to evaluate the gland 
function constituted a large proportion of the public 
health budget (4). For instance, 10 million thyroid 
functions have been done each year by laboratories 
which cost  30 million UK pounds, and they 
represent 8% of laboratory charge in the US (5).  
TSH measurement is a reliable test to diagnose 
all common forms of hypothyroidism and 
hyperthyroidism. Pituitary gland controls T4 
(thyroxin) and T3 (triiodothyronine) secretion with 
a corresponding negative feedback release of TSH 
by the pituitary (6,7)  Because of this log-linear 
relationship between the serum levels of T4, T3 and 
the production of TSH by the pituitary gland, 
minute changes in serum thyroxin and 
triiodothyronine have been found to induce 
significant changes in the  serum level of TSH. This 
implies that TSH can identify slight changes in 
thyroid hormone production and is therefore the 
best indicator of thyroid function (8). In normal 
individuals, when the TSH was within the 
reference range, there was a 99% likelihood that the 
FT4 will also be within the reference range (9) (1). 
Various standard guidelines to evaluate thyroid 
function have been developed based on the above 
phenomena (9,10). These algorithms and 
guidelines apply a cascade testing procedure to 
effectively evaluate functional thyroid status while 
avoiding extra laboratory costs (11). The cascade 
begins with a TSH test. If a patient has a normal 
pituitary–thyroid axis, the TSH level indicates 
normal physiologic thyroid hormone activity  (12). 
Guidelines that advocate cascade testing have   
multiple advantages than ordering the combination 
of tests. However they are not appropriately and 
uniformly practiced by physicians (13).   
  Costs from such unnecessary routine requests 
of thyroid function tests (TFTs) are increasing, as 
indicated by studies that showed that the frequency 
of ordering TFT is higher than that for the TSH 
only test. The cost of performing a TFTs test is 
substantially higher than that for the TSH only test  
(14,15). 
Consequently, the cost for a primary thyroid 
test to evaluate gland function constituted a large 
proportion of the public health budget  (4). For 
instance, 10 million thyroid function tests are 
performed each year by laboratories at a cost of 30 
million UK pounds; these tests also represent 8% 
of laboratory charges in the US (5). A study at a 
student clinic showed that the cost of TFTs could 
be reduced ten-fold if the standard diagnostic 
protocol were used (16). Similarly, when a TSH-
only protocol (guideline) was used, 95% of the 
requests were sufficient for diagnosis without 
requiring further tests, thereby resulting in a 50% 
savings on FT4 reagent and reducing the annual 
TFT reagent cost by 25 % (6). No similar study has 
been done in Ethiopia. This is an original study. 
The objectives were i)   to assess ordering pattern 
of TSH tests performed between July 2015 and 
June 2016, and  ii) to determine the unnecessary  
cost of  thyroid function tests performed between 
July 2015 and June 2016. Results were compared 
with the current guidelines, and cost effectiveness 
was analyzed.  
 
MATERIALS AND METHODS 
 
The study was conducted in International Clinical 
Laboratory (ICL) Addis Ababa, Ethiopia. An 
institution-based cross-sectional study design was 
utilized to study the ordering pattern of thyroid 
function tests using one-year retrospective data 
from the ICL.  
The study sources were records of all blood 
samples that  were analyzed at the immunoassay 
system of the International Clinical Laboratories 
between July 2015 and June 2016 for  serum 
triiodothyronine (T3), thyroxine (T4),  thyroid-
stimulating hormone (TSH), combined thyroid 
function tests including (T3+T4), (TSH+T4), 
(TSH+T3+T4) and others.    
TSH, T3, T4, FT4 and FT3 were the assays 
performed. Determination of serum values was 
performed on an automated immunoassay analyzer 
(AIA), which functions according to the principle 
of fluoroimmunoassay. The normal reference 
ranges for variables were as follows: T3 = 0.58–
1.59 ng/ml, T4 = 4.8–11.72 µg/dl, FT3 = 1.71–
3.71 pg/ml, FT4 = 0.70 - 1.48 ng/dl and 
TSH = 0.35-4.94 µIU/ml. 
  In the study period, from July 2015 to May 
2016, the immunoassay unit of the ICL performed 
15,635 thyroid function tests from various parts of 
the country. Among these, 8,313 were from health 
facilities in Addis Ababa.  
An institution-based study conducted in India by 
Shalini Gupta to represented 46% of all thyroid 
tests performed (7). No similar studies for this 
proportion have been done in Ethiopia. This 46% 
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proportion was used to calculate the sample size 
using the formula for a single population 
proportion with an assumed 95% confidence 
interval and 5% margin of error and , proportion of 
TSH tests done out of all forms of thyroid tests 
(p=0.46.). The outcome was 382.The 382 tests 
from the Addis Ababa requests were selected from 
the 8313 tests in ICL   as follows: 
 Sampling procedure:  Systematic random 
sampling method was applied to select the sample. 
Records of all immunoassay tests performed 
between July 2015 and June 2016 was used as data 
source. Records of all single as well as combined 
thyroid function tests performed during the same 
period was used as sampling frame. The first date 
of sample collection was randomly chosen from a 
lottery that contains the dates of July 1 to July 10 
of the year 2015. 
Then, every tenth sample was taken until 
thirty-two or thirty-one thyroid tests were obtained 
in thirty days. This procedure was repeated on total 
thyroid tests performed monthly until the desired 
sample, 382, was achieved in the total 12 months 
between July 2015 and June 2016.  The tenth 
sample was chosen based on the observation that a 
minimum of 300 tests are performed every month 
which will allow the collection of the desired 
sample within the intended study period while 
allowing the sample collection to spread through 
twelve months. This allowed the study to cover and 
hence reflect on a one year test ordering practice. 
Data were entered and processed with SPSS 
statistical software to analyze the descriptive 
statistics i) for different combinations of thyroid 
tests ordered, ii) to determine the percentage of 
TSH and TFT tests ordered, and iii) to obtain the 
results of thyroid profile samples as well as thyroid 
hormone tests.  
An analysis of indirect and opportunity costs 
was not performed. Analysis of the direct costs 
incurred by ordering all forms of TFT and standard 
TSH test alone was made by simple accounting. 
Similarly, the direct cost of health care expenditure 
for diagnostic testing that can be saved was 
performed by simple cost analysis. 
Ethical approval was obtained from the 
Internal Review Board of the Addis Continental 
Institute of Public Health. After review, the ethical 
clearance letter was submitted to Addis Ababa 
Health Bureau, where it was reviewed and 
approved. Data collection was performed after 




Among 8313 thyroid function tests referred to ICL 
from health facilities in Addis Ababa, 382 requests 
were selected for this study. Maximum samples 
were requested for age group 31 to 40 for both 
sexes (Table 1). Combined thyroid function tests 
containing TSH were included in 75.7% of the 
samples and thyroid stimulating hormone only test 
was performed in 24.3% (Figure 1). 
analyze the ordering pattern of thyroid-related 
tests, referred by clinicians to an endocrine 
laboratory, showed that TSH tests  
 
 Table 1: Sex by age distribution of patients for whom thyroid function tests were performed at ICL between 
July 2015 and June 2016:  Page 11, line# 3 &5, Results section 
 

















0 91+ Total 
Sex             
Male 3 6 3 15 20 21 17 10 6 3 1 105 
 0.8% 1.6% 0.8% 3.9 5.2% 5.50% 4.5% 2.60% 1.6% 0.8% 0.3% 27% 
Female 3 7 17 60 68 52 39 24 7 0 0 277 
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Figure 1: Analysis of ordering pattern for different combinations of thyroid tests performed at ICL 
between July 2015 and June 2016; Page 11 Line #5, Results section 
 
All of the 382 requests contained TSH tests. Out of 
the total 382 TSH tests performed in the form of 
TSH only requests, TSH included in panel 
(TSH+T3+T4) and in other combinations; 72.8% 
samples had results within the reference interval.  
 
Twelve percent of samples had TSH results higher 
and 15.2% had values lower than the reference 
range. The proportion of TSH samples with normal 
results was 78.49% among TSH only requests 
while 70.93% of TSH in the combination samples 
had their values in the reference range (Table 2). 
Table 2: Analysis of results of TSH samples performed at ICL between July 2015 and June 2016 Page 11 
line# 111 and 13 ,Results section
 
The total number of combination tests performed 
were 289. Of these, 64.7% had results within the 
normal reference range while 35.3% had results 
above and below the normal range (Table 2). The 
combination test containing FT4 and TSH had the 
highest proportion, 88.23% while 59% of the 
93

































































Number of Tests performed






   Number of 
tests   
   with normal 
TSH 
 Number of 
tests   
    with High 
TSH 
 Number of 
tests   
 with Low 
TSH 
          Total 
   
  
73 (78.49%)     8 (8.6%)  12(12.9%)   93(100%) TSH only samples  
Total TSH (all TSH tests 
found   
205(70.93%)   38(13.14%) 46(15.91%)  289(100%) 
in all types of combined 
samples)  
Total   278 (72.8%) 46 (12.0%) 58 (15.2%) 382(100.0%) 
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combination test containing TSH, FT3 and FT4 had 
values within the reference range (Table 3). 
  There were 529 individual tests (T3, T4, FT3, 
and FT4) components of the profile and 
combination tests. The majority of these tests 
(86.2%) turned out to be normal, while 9.1% were 




Table 3. Analysis of results of profile (combination) tests performed at ICL between July 
2015 and June 2016; Page 8, Line #17, Results section. 
 
Test    Normal results Abnormal results Total 
TSH+T3+T4 120 (63.49%) 69 (36.51%) 189  
TSH+FT3+FT4 30 (59%) 21 (41%) 51  
TSH+T3  9 (75.00%) 3 (25%) 12  
TSH+T4  6 (85.70%) 1 (14.30%) 7  
TSH+FT3  7 (53.84%) 6 (46.16%) 13  
TSH+FT4   15 (88.23%) 2 (11.77%) 17   
Total   187 64.70% 102 (35.30%) 289   
 
Table 4: Analysis of results of individual tests included in profile / combination samples performed at ICL 
between July 2015 and June 2016; Page 12, line # 3 
Test type  Normal  High  Low Total 
FT3 52 (81.2) 8 (12.5%) 4 (6.2%) 64 (100.0%) 
FT4 58 (81.2) 7 (12.5) 3 (6.2) 68 (100.0%) 
T3 175 (87.1%) 23 (11.4%) 3 (1.5%) 201 (100.0%) 
T4 171 (87.2%) 10 (5.1%) 15 (7.7%) 196 (100.0%) 
Total 456 (86.2%) 48 (9.1%) 25 (4.7%) 529 (100.0%) 
The difference in Ethiopian Birr between the price 
for each combination test and that of TSH only test 
ranged from 170 to 375 Eth Br (7.4-16.2USD). 
This was used to calculate extra expenditure by 
patients for having the combination tests that had 
their results within reference range for all 
parameters performed (Table 5). 
The amount of money spent on combined or 
panel tests that turned out normal was 60260 
Ethiopian Birr (2625.70USD). The TSH tests done 
along with each of these tests were also in the 
normal range. The shown amount does not include 
the money patients pay for the TSH test.This 
money is paid by patients to have the individual 
components in the profile tests performed (Table 
5). 
Thyroid profile had the highest proportion in 
which 41400 Eth. Birr (1803 USD) was spent on 
tests with normal values the diagnosis of which 
could have been made by performing TSH only 
tests. The combination test TSH+FT3+FT4 was 
second causing an unnecessary expenditure of 
1125 Eth. Birr (490 USD). The total amount of 
expenditure incurred on the 187 patients was 60260 
Eth. Birr (2625 US) (Table 5). 
The amount of expenditure on reagents for 
performing the same tests was calculated in the 
same manner as for the direct cost for patients. As 
presented in table 5 it was 18,853 Eth. Birr 
(821.48USD). This was an additional reagent cost 
to the company due to each combination test 
ranged was 49 to 116 Eth. Birr according to the 
type of test ordered. 
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Table 5: Unnecessary expenditure by patients for individual tests included in a combination request that 
had normal results at ICL during July 2015 and June 2016; Page 12, line #7, 11, 16 Results section and 
Page 16, line 12, Discussion section. 
 
DISCUSSION 
In this study, the TSH only test accounted for 
only one-fourth and combination (profile) 
samples for three-fourths of the requests, while 
the opposite result was expected according to 
the standard guidelines to evaluate thyroid 
function. An unnecessary 60260 Ethiopian 
Birr (2625.70 USD) and 18853 Ethiopian Birr 
(821.48 USD) additional cost was incurred on 
patients and health facilities respectively, due to 
ordering a high proportion of profile or 
combination tests by clinicians. This shows that 
although the guidelines favor TSH as the screening 
test for thyroid dysfunction, the use of combination 
tests is more common. 
Apart from a few cases, the results of the 
combination TFT were not remarkable or did not 
have abnormal results.  The findings of the study  
which revealed that 78% of TSH tests, 65 to 88% 
of combined tests, as well as 86% of thyroid 
hormone tests to have normal results also suggests 
that the majority of the  cases could have been 
diagnosed by clinical impression only. The 
observation that almost half of the requests were 
for profile tests was similar to a study   in India by 
Shalini Gupta et al where 47.5% of requests were 
for profile samples (6). It can be observed that the 
majority of the clinicians are not sticking to 
cascade testing for thyroid function tests.  
There was no significant difference in the 
proportion of normal TSH levels when all the TSH 
tests done during the study period were taken into 
consideration: TSH only tests had normal   results 
in 78.49% of tests,  while 70.9% of TSH included 
in  combined tests had results in the reference 
range. This is similar to the finding of 79.2% in the 
study by Shalini Gupta et al (6). This can imply that 
estimation of thyroid hormones gives no additional 
information in the majority of patients other than 
confirmation of normality.  
 The majority (65%) of combination tests   had 
results within the reference interval for all the three 
parameters and thus excluded thyroid disorder 
making the likelihood of thyroid dysfunction 
around one in every seven patients presumed to 
have it. This finding is in conformity with the 
existing knowledge that  99% of blood  tests for 
thyroid hormones fall within normal range if TSH 
is normal (9,17). This implies the thyroid function 
status of these patients with normal results for all 
parameters could have easily been determined by 
performing TSH only tests alone. This finding is 
similar but a little lower than the proportion in a 
study by Shalini et al in which the percentage was 
around 77 % (6). 
The fact that the majority of the individual tests 
(T3, T4, FT3 and FT4) turned out to be normal 
(86.2%) which rules out presence of thyroid 
dysfunction indicates indiscriminate test ordering.  
This is in line with similar study by Shalini Gupta 
et al in which 86.2% were normal (6).  
An analysis of the patient and reagent cost was 
used to estimate the difference in expenditure 
between ordering only the TSH test and 
combination tests. The majority of the combination 
requests had results within the normal range. This 
implies that adding the same number of tests to the 
TSH in each combination could have been avoided 
if the cascade testing was applied in which TSH is 

























TSH+T3+T4 120 520 62400 175 21000 345 41400 
TSH+FT3+F
T4 30 550 16500 175 5250 375 11250 
TSH+T3  9 345 3105 175 1575 170 1530 
TSH+T4 6 345 2070 175 1050 170 1020 
TSH+FT3 7 405 2835 175 1225 230 1610 
TSH+FT4  15  405 6075 175 2625 230 3450 
Total 187   92985   32725   60260 
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resources could have been saved. This is further 
highlighted by the fact that these tests are not 
available everywhere and that the few facilities 
performing these tests are burdened with an 
unnecessary workload. 
Thyroid profile (TSH+T3+T4) had the highest 
proportion, and 41,400 Ethiopian Birr (1,803 USD) 
was spent on tests with normal values for which the 
diagnosis could have been made by performing 
only a TSH test. The combination test 
TSH+FT3+FT4 was second, causing an 
unnecessary expenditure of 11,250 Ethiopian Birr 
(490 USD). The total amount of expenditure 
incurred on the 187 patients was 60,260 Ethiopian 
Birr (2,625 USD) (Table 5). These funds could 
have been saved if only a TSH test was ordered for 
these patients. A similar observation was made by 
Kawfehr El Shafe et al. in a study in Oman in which 
only 6% of the tests administered had positive 
results, resulting in an unnecessary TFT 
expenditure amounting to 18,800 USD. A similar 
result was also found in a study by Anthony Viera 
et al (16,18). 
The expenditure on reagent for the same 
number of tests was 18853 Eth. Birr (821 USD). 
This money could have been spent for procurement 
of other reagents for tests that are of high demand. 
The cost-savings reported here are total 
incremental direct costs (reagents and labor). This 
finding is in line in its context with a study by 
Anthony Viera et al   in which it was shown that if 
combination test had not been ordered on the 1,192 
specimens with normal TSH results, the actual 
material cost savings over the 26-month study 
period would have been more than $3, 360 (18). 
A five-year data of blood tests for thyroid 
function at ICL was analyzed for further inference. 
In the five years, 47144 all forms of thyroid 
function tests were performed of which TSH only 
tests accounted for 25% while 75% were combined 
tests. A large majority (75%) of the requests were 
for combination tests. This is in conformity with 
the finding of this study on the 382 samples in 
which 75.7% of the blood tests ordered were for 
combination tests. This again demonstrates that 
clinicians in health facilities that refer samples to 
ICL prefer to order combination /profile thyroid 
tests than TSH tests as opposed to the 
recommended teaching of using algorithm or 
cascade testing. This finding is even greater than 
the observation of a study in India by Shalini Gupta 
in which TFT was ordered in 54% of cases (6). 
Analysis of cost was made on the combination 
tests performed in the five years.  The percentage 
of normal tests among each combination test was 
used to make extrapolation of expenditure by 
patients for whom the combination tests were 
performed. 
Projected cost savings calculation was based 
on initial observations in the current study. Overall, 
63.5% of profile (TSH+T3+T4), 59% of 
(TSH+FT3+FT4), and 75% of (TSH+T3) were 
normal. .Likewise 85.7% of (TSH+T4), 53.8% of 
(TSH+FT3) and 88.2% of (TSH+FT4) requests had 
results within the normal range. By this projection 
22560 of the 35360 requests were for TSH+T3+T4 
test. 
In the current study, the percentage of tests 
with normal results for this combination was 
63.49% which makes the number of normal tests 
14325.6 out of the 22560. The price for 
TSH+T3+T4 test is 520 Eth. Birr while that of 
single TSH test is 175 and this makes the extra 
payment 345 Eth. Birr for a single test. Multiplying 
this difference,(345EthBirr), by the number of 
normal tests in 5 years which were 14325.6 
amounts to 4,942,332 Eth. Birr (215,352.15 USD). 
This is the extra financial burden incurred on 
patients due to all TSH +T3+T4 tests with normal 
results in the five year period. Likewise, the total 
expenditure that could have been saved by initially 
requesting TSH only tests   in each of the six types 
of the combination requests was analyzed and the 
sum total amounted to 7,417,413.10 Eth. Birr 
(323,198.82 USD). 
The cost of the reagent required to perform 
these tests was 2,339,745.70Eth. Birr (101,949.70 
USD). This implies a total of 9,757,158.80 Eth. 
Birr (425,148,53 USD) could have been saved and 
used for other purposes if an initial TSH only test 
was ordered for these patients as per the guideline. 
This finding is consistent with the study by Geoff 
Beckett et al who found that 30 million pounds 
were spent on TFT each year in the UK (5).  
The most significant conclusion that can be 
made is that the use of thyroid profile and other 
combination tests is common and results in an extra 
financial burden for patients and the healthcare 
system.  This study had large sample size which was 
adequate for statistical inference and projection. Data 
were complete for all variables and were from an 
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internationally accredited laboratory. Lack of data on 
specific clinical reason for requesting combination 
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